HBEGF and cancer: Thus, our results demonstrate that mAb 2-108 is the first mAb against human HB-EGF available for IHC of paraffin-embedded sections and suggest that this antibody will be a powerful tool for the study and diagnosis of HB-EGF-related cancers and other diseases.